News
-
-
PRESS RELEASE
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
Zomedica Corp. to host conference call on March 13, 2025, to discuss Q4 and FY 2024 financial results. Leading veterinary health company offering innovative solutions -
-
-
-
PRESS RELEASE
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
Zomedica announces groundbreaking update to the TRUFORMA biosensor platform with enhancements to the eACTH assay for equine plasma, providing valuable insights into Pituitary Pars Intermedia Dysfunction (PPID) diagnosis -
-
PRESS RELEASE
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
Zomedica Corp. partners with Cresilon, expanding portfolio with groundbreaking Vetigel® hemostatic gel to enhance veterinary care and surgical efficiency worldwide -
-
PRESS RELEASE
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
Zomedica launches two new assays for TRUFORMA Platform - canine NT-proBNP and progesterone tests for dogs. These assays provide precise in-clinic results for cardiac and reproductive conditions